November 14, 2018

Navigating Novo: A Map for Selling to Novo Nordisk

Born from the 1989 merger between Denmark’s top two insulin producers, Novo Nordisk markets products to over 165 countries. Learn how and where they make decisions about outsourcing activities in clinical research, contract manufacturing, logistics, and more.

July 23, 2018

Started From Aspirin™, Now They’re Here: A map for Selling to Bayer

Part 2 of our Sponsor Atlas: Selling to the Pharma Giants blog series. It's off to Germany for the latest stop on our expedition, to visit Bayer and understand how they make their outsourcing decisions and how best to find opportunities.

July 13, 2018

Sponsor Pipeline Insights: The Most Active Drug Companies in the American Northeast

For this edition of our Sponsor Pipeline Insights, we're taking a trip up to the American Northeast to check out the top 10 most active clinical study registrants.

June 26, 2018

Sponsor Pipeline Insights: The Most Active Drug Companies in New York

We live in a time where lists make up much of the content that appears in our timelines each day. So, why not ride the wave? Everybody loves a good list, after all! Here's a list of the top 10 most active drug sponsor companies in New York State.

May 16, 2018

Marketing vs. Sales: Their Major Difference and How They Work Together

Do your sales & marketing teams stand united or divided?

May 16, 2018

5 Sales Prospecting Tactics that Work for Biotech and Pharma Professionals

Prospecting is typically a dreaded part of the sales process. It goes something like this: Identify target companies. Search LinkedIn to see if you know anyone at the company. Place cold calls or send out generic emails and hope that you get a response. Rinse and repeat.

May 16, 2018

Can I still cold email European pharma companies under GDPR?

A guide to GDPR for service provider companies selling to pharmaceutical & biotech companies in Europe. With strict new regulations being implemented, how can you reach your potential customers?

May 15, 2018

Decisions, Decisions: A map for Selling to Novartis

Multinational giants like Novartis can be a tough sell for service provider companies when they don't know where to target. Understanding where decisions about different kinds of outsourced activities take place can help you close more new business. Join us for part one of our new series Sponsor Atlas: Selling to the Pharma Giants!